+++ EVER Pharma Launches Innovative, Patient Friendly Subcutaneous Pump for Parkinson´s Disease +++ EVER Pharma acquires Amneal Deutschland GmbH and extends its commercial presence in Europe +++ EVER Valinject launches Dexmedetomidine in Europe +++ Another First for EVER Pharma: EVER Pharma is pleased to announce the first Fulvestrant in Europe approved for storage at room temperature +++

About us

Portfolio

Service & Partnerships

Career

News & Events

EVER PHARMA GAINS EU MARKETING AUTHORIZATION FOR VALUE-ADDED CABAZITAXEL

EVER Pharma is pleased to announce EU-wide marketing authorization of Cabazitaxel...